QuantaLife
Pleasanton
About QuantaLife
QuantaLife, Inc. was formed to develop, manufacture and market a revolutionary nucleic acid testing concept for the Life Science Research, Clinical Molecular Diagnostics, Personalized Medical Care and Industrial markets. Our suite of products, which are based on our proprietary nucleic acid testing method, will enable rapid detection and quantification of nucleic acids in complex samples on a flexible, automated instrument. This technology provides an order of magnitude improvement in performance over current platforms at a fraction of the cost. QuantaLife is a small biotechnology startup involved in the early development phases of the technology.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $30.1M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2011)
- Website: bio-rad.comen-usproductdigital-pcrqx100-droplet-digital-pcr-system
- Phone: (925) 474-8600
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/quantalife-2633207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.